NJ State Employees Deferred Compensation Plan - TG THERAPEUTICS INC ownership

TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 255 filers reported holding TG THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.72 and the average weighting 0.3%.

Quarter-by-quarter ownership
NJ State Employees Deferred Compensation Plan ownership history of TG THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$765,776
-57.5%
91,600
+26.2%
0.12%
-55.4%
Q2 2023$1,803,384
+65.2%
72,6000.0%0.26%
+53.8%
Q1 2023$1,091,904
+27.1%
72,6000.0%0.17%
+21.6%
Q4 2022$858,858
+99.7%
72,6000.0%0.14%
+87.8%
Q3 2022$430,000
+273.9%
72,600
+168.9%
0.07%
+289.5%
Q2 2022$115,000
-55.3%
27,0000.0%0.02%
-45.7%
Q1 2022$257,000
-49.9%
27,0000.0%0.04%
-46.2%
Q4 2021$513,000
-42.9%
27,0000.0%0.06%
-46.7%
Q3 2021$899,000
-14.1%
27,0000.0%0.12%
-12.2%
Q2 2021$1,047,000
-19.5%
27,0000.0%0.14%
-24.9%
Q1 2021$1,301,000
-7.4%
27,0000.0%0.18%
-14.7%
Q4 2020$1,405,000
+94.3%
27,0000.0%0.22%
+66.9%
Q3 2020$723,000
+37.5%
27,0000.0%0.13%
+31.3%
Q2 2020$526,000
+97.7%
27,0000.0%0.10%
+62.3%
Q1 2020$266,000
-11.3%
27,0000.0%0.06%
+19.6%
Q4 2019$300,000
+97.4%
27,0000.0%0.05%
+82.1%
Q3 2019$152,00027,0000.03%
Other shareholders
TG THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Opaleye Management Inc. 1,890,000$15,800,4005.14%
Ghost Tree Capital, LLC 1,000,000$8,360,0002.75%
Soleus Capital Management, L.P. 2,884,382$24,113,4342.22%
M28 Capital Management LP 216,600$1,810,7762.08%
Paradigm Biocapital Advisors LP 3,619,015$30,254,9652.05%
683 Capital Management, LLC 1,350,000$11,286,0000.88%
Parkwood LLC 165,414$6,0810.66%
Spotlight Asset Group, Inc. 79,000$660,4400.60%
Pier Capital, LLC 392,709$3,283,0470.53%
Quantum Private Wealth, LLC 91,081$761,4380.36%
View complete list of TG THERAPEUTICS INC shareholders